Skip to main content
Sunday, November 15, 2026Nov 15

Abu-Jamal loses suit over hepatitis C drug; can refile

FILE - In this July 12, 1995 file photo, Mumia Abu-Jamal leaves Philadelphia's City Hall after a hearing. A federal judge in Pennsylvania has blasted a prison policy that denies former death-row inmate Abu-Jamal and others an expensive hepatitis C drug until they have advanced liver damage. Abu-Jamal is serving a life term for the 1981 killing of a Philadelphia police officer. He is a former Black Panther and radio reporter.  (AP Photo/Chris Gardner, File)
FILE - In this July 12, 1995 file photo, Mumia Abu-Jamal leaves Philadelphia's City Hall after a hearing. A federal judge in Pennsylvania has blasted a prison policy that denies former death-row inmate Abu-Jamal and others an expensive hepatitis C drug until they have advanced liver damage. Abu-Jamal is serving a life term for the 1981 killing of a Philadelphia police officer. He is a former Black Panther and radio reporter. (AP Photo/Chris Gardner, File)

SCRANTON, Pa. (AP) – A federal judge in Pennsylvania has blasted a prison policy that denies former death-row inmate Mumia Abu-Jamal and others an expensive hepatitis C drug until they have advanced liver damage.

U.S. District Judge Robert Mariani says the policy amounts to “conscious disregard” for prisoners’ health, but notes that courts across the country are struggling to decide who should get the drugs.

The judge on Wednesday rejected Abu-Jamal’s lawsuit after finding he sued the wrong prison officials. His lawyers say they will refile it to include the hepatitis treatment committee.

Experts told the judge the latest antiviral drugs are highly effective at curing hepatitis.

The 62-year-old Abu-Jamal is serving a life term for the 1981 killing of a Philadelphia police officer. He is a former Black Panther and radio reporter.